FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 336:1761 June 12, 1997 Number 24 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Cancer after transplantation has long been recognized to be a risk associated with immunosuppression, but Kaposi's sarcoma is a rare tumor in this situation.¹ A 39-year-old man with end-stage renal disease received an allograft from a living related donor in 1992. He was receiving steroids, azathioprine, and cyclosporine and had stable renal function. Eighteen months after transplantation, a cluster of pigmented lesions appeared in his right calf. Histologic evaluation revealed an infiltrating spindle-cell tumor around eccrine ducts, with hyaline globules and hemosiderin among the slit-like vascular pores — features consistent with Kaposi's sarcoma (Figure 1).

View larger version (17K): [in this window] [in a new window]   Figure 1. . . . [Full Text of this Article]

 
References

This article has been cited by other articles:

• Hussein, M. M., Mooij, J. M., Roujouleh, H. M. (2000). Regression of post-transplant Kaposi sarcoma after discontinuing cyclosporin and giving mycophenolate mofetil instead. Nephrol Dial Transplant 15: 1103-1104 [Full Text]  
• Searles, R. P., Bergquam, E. P., Axthelm, M. K., Wong, S. W. (1999). Sequence and Genomic Analysis of a Rhesus Macaque Rhadinovirus with Similarity to Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8. J. Virol. 73: 3040-3053 [Abstract] [Full Text]